In addition to the aforementioned methods, we also determined the concentration of certain CS constituents.
We determined the concentration of total protein in the BALF to assess pulmonary vascular leakage.
We thereafter determined the concentration of inhibitor in the testis and we discovered that the compound was slightly present.
We also performed chemical analysis of plant samples, and determined the concentration of phenanthrene remaining in soil.
We next determined the concentration of TNFα in the culture supernatants to assess whether the particles would elicit an inflammatory response.
We thus determined the concentration of atherogenic small, dense LDL (sdLDL) in patients with type 2 diabetes and an elevated cardiovascular risk profile.
Further, the composite modified electrode successfully determined the concentration of Rut in the presence of 250-fold higher concentration of one of the major interferents, ascorbic acid.
In order to investigate this assumption and to characterise potential cross-reacting hormones in more detail, we performed high-performance liquid chromatographic (HPLC) analyses of chicken yolk extracts and determined the concentration of immunoreactive corticosterone, progesterone and cortisol.
Using this system, we successfully measured the temperature variations (from 66.33 ± 2.72 °C to 74.16 ± 2.06 °C) of whole blood samples from 10 anemic patients and subsequently determined the concentration of hemoglobin (from 7.2 g/dL to 9.8 g/dL).
For each cluster of contaminant pathways, PHREEQC-2 determined the concentration for mass-transfer, sorption/desorption, ion exchange, mineral dissolution/precipitation and biodegradation, under kinetically controlled reactive processes of equilibrated chemical species.
For the DAX-8-adsorbed and DAX-8-non-adsorbed fractions, a divided portion of the fractions was dissolved in 800 μL of 0.1 M NaOH and determined the concentration of total organic carbon in the same manner as described above.
